Pharmaceuticals

Global Oligonucleotide Therapy Industry Trends and Market Forecast 2026–2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the oligonucleotide therapy market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Oligonucleotide Therapy Market show for the 2026–2030 period?

The oligonucleotide therapy market size has experienced significant growth in recent years. It is anticipated to increase from $6.2 billion in 2025 to $6.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.5%. This historical expansion can be credited to factors such as increased research and development in oligonucleotide synthesis, a rising need for targeted therapies, progress in molecular biology techniques, the escalating prevalence of chronic and genetic diseases, and the initial embrace of antisense and aptamer technologies.

The oligonucleotide therapy market is anticipated to experience substantial growth over the upcoming years. It is projected to expand to $10.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.0%. This expected growth during the forecast period is primarily driven by factors such as the expansion of personalized medicine, the integration of AI in drug discovery, the progress of precision medicine initiatives, the evolution of next-generation delivery platforms, and increasing collaborations between biotech and pharmaceutical companies. Key trends shaping the forecast period include targeted gene regulation, RNA interference-based therapeutics, advancements in personalized medicine, sophisticated drug delivery systems, and nucleic acid-based diagnostics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

What Drivers Are Shaping The Development Of The Oligonucleotide Therapy Market?

Government initiatives focused on research and development within the healthcare sector are anticipated to fuel the future expansion of the oligonucleotide therapy market. These government initiatives encompass specific actions, programs, policies, or projects implemented by government authorities at various levels—local, regional, national, or international—to tackle particular issues, achieve set objectives, or foster positive societal transformations. Numerous government bodies are launching diverse healthcare initiatives to support multiple aspects, including oligonucleotide therapy. For example, according to the American Medical Association, a US-based professional organization, in April 2025, U.S. health spending escalated by 7.5% to $4.9 trillion, or $14,570 per capita, in 2023, surpassing the 4.6% increase observed in 2022. Consequently, government initiatives for research and development in healthcare are actively propelling the growth of the oligonucleotide therapy market.

What Segment Types Are Examined In The Oligonucleotide Therapy Market?

The oligonucleotide therapy market covered in this report is segmented –

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User

3) By End User: Hospitals, Research Institutes

Subsegments:

1) By Antisense Oligonucleotide: RNA-Targeted Antisense Oligonucleotides, DNA-Targeted Antisense Oligonucleotides, Chemically Modified Antisense Oligonucleotides

2) By Aptamer: DNA Aptamers, RNA Aptamers, Small Molecule Aptamers

3) By Other Types: siRNA (Small Interfering RNA), miRNA (Micro RNA), DNAzyme And Ribozymes, Synthetic Oligonucleotides For Gene Editing

What Long-Term Trends Are Expected To Shape The Future Of The Oligonucleotide Therapy Market?

Leading companies within the oligonucleotide therapy market are concentrating on creating innovative treatments, notably gene therapies, with the goal of tackling the fundamental causes of genetic illnesses, enhancing patient results, and lessening the strain of extended treatments. These gene therapies are sophisticated medical interventions designed to insert a working gene into a patient’s cells, thereby compensating for a gene that is either dysfunctional or mutated. An example of this is Sarepta Therapeutics Inc., a biotechnology company based in the US, which in June 2023 obtained approval from the Food and Drug administration (FDA) for its product ELEVIDYS. This product stands as a groundbreaking gene therapy specifically for pediatric patients with Duchenne muscular dystrophy (DMD) who are still able to walk. As a single-dose treatment, it is engineered to introduce a gene that produces a shortened, functional variant of dystrophin into muscle cells, intending to arrest or even reverse the illness’s advancement.

Who Are The Top-Performing Companies In The Oligonucleotide Therapy Market In Recent Years?

Major companies operating in the oligonucleotide therapy market are Pfizer Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Avidity Biosciences Inc., Miragen Therapeutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Evox Therapeutics Ltd., PepGen Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Which Region Currently Holds The Largest Share Of The Oligonucleotide Therapy Market?

North America was the largest region in the oligonucleotide therapy market in 2025. The regions covered in the oligonucleotide therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oligonucleotide Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3398&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Therapy Market 2026, By The Business Research Company

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795